| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V16227 | TH-1318 | 1258494-60-8 | TH-1318 is novel brain penetrable antitumor agent, not acting as substrates for any of the major clinically relevant efflux pumps (MDR1, MRP1, and BCRP) |
|
V16264 | Thiambutosine | 500-89-0 | Thiambutosine was a candidate for treatment of lepromatous leprosy. |
|
V10535 | TIC10 (imipridone, ONC201) HCl | 1638178-82-1 | TIC10 (imipridone, ONC-201) HCl isa novel, potent, orally bioactive, brain penetrant, and stable tumor necrosis factor-related apoptosis-inducing ligand(TRAIL)inducer which acts by inhibiting Akt and ERK, consequently activating Foxo3a and significantly inducing cell surface TRAIL. |
|
V16424 | Ticagrelor metabolite M5 | 1251765-07-7 | Ticagrelor metabolite M5 is a metabolite/impurity ofTicagrelor(AZD-6140;AR-C126532XX; Brilinta; Brilique; Possia) which is a P2Y12 receptor antagonist used as an antiplatelet and anticoagulant. |
|
V16464 | Timosaponin AIII | 41059-79-4 | Timosaponin AIII is a novel and potent acetylcholinesterase (AChE) inhibitor (IC50 = 35.4 μM) and also an inhibitor of U46619-induced rat platelet aggregation. |
|
V16467 | Tinostamustine HCl | 1793059-58-1 | Tinostamustine HCl (formerly known as EDO-S101 and Minomustine), the hydrochloride salt ofTinostamustine,is a dual alkylating agent and histone-deacetylase inhibitor (HDACi) and a fusion molecule. |
|
V16514 | TM N1324 | 1144477-35-9 | TM-N1324 is an agonist of G protein-coupled receptor 39 (GPR39). |
|
V16525 | TMC647055 | 1204416-97-6 | TMC647055 (TMC-647055) is a potent HCV NS5B polymerase inhibitor with the potential to be used for the treatment of HCV infection. |
|
V16553 | Tofisopam | 22345-47-7 | Tofisopam (EGYT-341; EGYT341; Emandaxin, Grandaxin, Sériel) is a potent anxiolytic drug approved in some countries in the EU, acting asa GABAA receptor ligand and modulator. |
|
V12793 | Tosufloxacin tosylate (A61827) | 115964-29-9 | Tosufloxacin tosylate, formerly known as T-3262 andA-61827, is a potent fluoroquinolone antibiotic used to treat susceptible infections. |
|
V16659 | TP808 | 852821-06-8 | TP808 is a useful intermediate for the synthesis of diverse tetracycline antibiotics. |
|
V16676 | TPT-260 2HCl (R55) | 2076-91-7 | TPT-260 DiHCl (NSC55712) is a thiophene thiourean analogue. |
|
V41375 | Trapoxin A | 133155-89-2 | Trapoxin A, a cyclotetrapeptide,is a potent histone deacetylase (HDAC) inhibitor with potential anticancer activity. |
|
V16717 | Trenbolone | 10161-33-8 | Trenbolone is a novel and potent anabolic steroid |
|
V13766 | Triazavirin sodium (Riamilovir, TZV) | 116061-59-7 | :Triazavirin sodium (TZV, Riamilovir), a nucleoside analogue of nucleic acid, is a broad-spectrum and potent antiviral agent. |
|
V16805 | Triheptanoin | 620-67-7 | Triheptanoin (IND-106011; UX-007; Dojolvi) is a novel and potent fatty acid metabolic modulator and a triglyceride used for the treatment of inherited metabolic diseases, epilepsy, ventricular hypertrophy and myocardial glucose oxidation. |
|
V16817 | Trimegestone | 74513-62-5 | Trimegestone (TMG; tradenames Ondeva and Totelle among others) is an approved a synthetic progestin medication used in menopausal hormone therapy and in the prevention of postmenopausal osteoporosis. |
|
V16858 | Triptorelin Acetate | 140194-24-7 | Triptorelin Acetate (CL-118532;AY-25650;Wy-42462; decapeptyl; trelstar), the acetate salt ofTriptorelin,is a gonadotropin-releasing hormone agonist (GnRH agonist) approved for use as the acetate or pamoate salts to treat cancer. |
|
V16859 | Triptorelin pamoate | 124508-66-3 | Triptorelin pamoate (AY25650;Wy42462;CL118532;AY-25650;Wy-42462; decapeptyl; trelstar), the pamoate salt of triptorelin, is a gonadotropin-releasing hormone agonist (GnRH agonist) used to treat advanced prostate cancer in men. |
|
V16864 | Trityllosartan | 133909-99-6 | Trityllosartan is a key intermediate in the synthesis of Losartan impurities. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
